ELLXF - Elixinol Wellness Limited

Other OTC - Other OTC Delayed price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 4.59M
Enterprise value 3.96M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.78
Price/book (mrq)0.83
Enterprise value/revenue 0.56
Enterprise value/EBITDA -0.43

Trading information

Stock price history

Beta (5Y monthly) 1.72
52-week change 3-60.43%
S&P500 52-week change 32.92%
52-week high 30.0390
52-week low 30.0081
50-day moving average 30.0124
200-day moving average 30.0168

Share statistics

Avg vol (3-month) 36.97k
Avg vol (10-day) 37.65k
Shares outstanding 5436.49M
Implied shares outstanding 6N/A
Float 8274.39M
% held by insiders 115.23%
% held by institutions 13.96%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in AUD.

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Dec 2022


Profit margin -149.84%
Operating margin (ttm)-138.20%

Management effectiveness

Return on assets (ttm)-31.40%
Return on equity (ttm)-74.88%

Income statement

Revenue (ttm)7.05M
Revenue per share (ttm)0.02
Quarterly revenue growth (yoy)-15.60%
Gross profit (ttm)2.98M
Net income avi to common (ttm)-10.57M
Diluted EPS (ttm)-0.0200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.86M
Total cash per share (mrq)0.01
Total debt (mrq)1.9M
Total debt/equity (mrq)20.79
Current ratio (mrq)2.71
Book value per share (mrq)0.03

Cash flow statement

Operating cash flow (ttm)-8.15M
Levered free cash flow (ttm)-5.81M